Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics

Fig. 3

MiRNAs and lncRNAs as therapeutics in diabetes-induced cardiomyopathy. ↑ indicates the mimic-use as treatment, ↓ indicates inhibitor-use as treatment against diabetic cardiomyopathy. ANRIL antisense non-coding RNA in the INK4 locus, H19 imprinted maternally expressed transcript, HOTAIR HOX transcript antisense intergenic RNA, IL interleukin, Kcnq1ot1 KCNQ1 overlapping transcript 1, lncRNA long non-coding RNA, MALAT1 metastasis-associated lung adenocarcinoma 1, miRNA microRNA, miR; mRNA messenger RNA, TGFβ transforming growth factor β, TNFα tumor necrosis factor-alpha

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840